|
1st Annual Symposium of Bacteriology and Infection (SBI)
|
SBI 1: Old vs New Antibacterial Targets of Superbugs
Time: 13:30-16:20, July 30, 2011 (Saturday); Place: Room No.310, 3rd Floor, BICC
|
|
Chair:
|
Dr. Isabelle J. Schalk, Director, University of Strasbourg-CNRS, France
|
|
13:30-13:55
|
Title: Iron Uptake Pathways in Pseudomonas Aeruginosa: Targets for New Antibiotics
Dr. Isabelle J. Schalk, Director, University of Strasbourg-CNRS, France
|
|
13:55-14:20
|
Title: The Function and Structure of sodB Gene in Malaysia and Australia Isolates of Legionella Pnuemophila: A Possible New Drug’s Targeted Site
Dr. Stacey F Y Yong, Dean, Taylor's University, Malaysia
|
|
14:20-14:45
|
Title: Antibacterial and Antivirulent Drugs Targeting Bacterial Histidine Kinases
Dr. Ryutaro Utsumi, Professor, Kinki University, Japan
|
|
14:45-15:10
|
Title: Signaling Pathway for Lysophosphatidylcholine-induced Enhancement of Neutrophil Bactericidal Activity
Dr. Dong-Keun Song, Professor, Hallym University College of Medicine, South Korea
|
|
15:10-15:30
|
Coffee Break
|
|
15:30-15:55
|
Title: Activity of the Peptides Designed to Target the BAM Complex in Pseudomonas Aeruginosa
Dr. Eisaku Yoshihara, Associate Professor, Tokai University School of Medicine, Japan
|
|
15:55-16:20
|
Title: Orthodox and Un-orthodox Antimicrobial Therapies for MDR Gram-negative Infections
Dr. David W Wareham, Senior Clinical Lecturer, Queen Mary University London, UK
|
|
SBI 2: Tuberculosis
Time: 13:30-16:20, July 30, 2011 (Saturday); Place: Room No.311A, 3rd Floor, BICC
|
|
Chair:
|
Dr. John T. Belisle, Professor & Director, Colorado State University, USA
|
|
13:30-13:55
|
Title: Setting Up a New Platform for Fast and Portable Diagnosis of Tuberculosis
Dr. Giovanni Musci, Professor, University of Molise, Campobasso and GoDiagnostics s.r.l., Italy
|
|
13:55-14:20
|
Title: Targeting Small Molecules for Tuberculosis Diagnostics and Treatment Prognosis
Dr. John T. Belisle, Professor & Director, Colorado State University, USA
|
|
14:20-14:45
|
Title: Emerging and Re-emerging Potentially Pathogenic Mycobacteria - Current Situation, Ecology and Impact on Animal's and Human's Health
Dr. Ivo Pavlik, Professor & Head, Veterinary Research Institute, Czech Republic
|
|
14:45-15:10
|
Title: Tuberculosis Risk in Health Care Workers & Trainees
Dr. Devasahayam Jesudas Christopher, Professor & Head, Christian Medical College, India
|
|
15:10-15:30
|
Coffee Break
|
|
15:30-15:55
|
Title: Tuberculosis Diagnostics: "If Simple does not Work then Make the Complex Simple: A mycobacterial compromise"
Dr. Richard M. Anthony, Research Coordinator Tuberculosis, KIT-BR Amsterdam, The Netherlands
|
|
15:55-16:20
|
Title: The Usefulness of Focus ChangingExamination in Gram Staining as Initial Diagnostic Clue for Tuberculosis
Dr. Hajime Nishiya, Senior Researcher, Teikyo University School of Medicine, Japan
|
|
SBI 3: NDM-1 and Multidrug Resistance
Time: 15:30-17:10, July 30, 2011 (Saturday); Place: Room No.311B, 3rd Floor, BICC
|
|
Chair:
|
Dr. María M. Tavío, Professor, University of Las Palmas de Gran Canaria, Spain
|
|
15:30-15:50
|
Keynote Speech:
Title: Role of Multidrug Efflux Pumps in Multidrug Resistance of Burkholderia Pseudomallei
Dr. Herbert P Schweizer, Professor, Colorado State University, USA
|
|
15:50-16:10
|
Title: The SdiA Regulon: Environmental Conditions that Influence Its Expression
Dr. María M. Tavío, Professor, University of Las Palmas de Gran Canaria, Spain
|
|
16:10-16:30
|
Title:Infection Control - Concerning NDM-1 in Extensively Drug-resistant Gram-negative Rods
Dr. Bjørg Marit Andersen, Professor & Head, Oslo University Hospital and Diakonova University College, Norway
|
|
16:30-16:50
|
Title: Multidrug-resistant Pathogens and Antimicrobial Therapy Options in Intensive Care
Dr. Maria Joao Oliveira, Clinical Pharmacist, Hospital Prof. Dr. Fernando Fonseca and Faculty of Pharmacy of University of Lisbon, Portugal
|
|
16:50-17:10
|
Title: A Molecular View on Multidrug Resistance
Dr. Henrietta Venter, Research Fellow, University of Cambridge, UK
|
|
SBI 4: Methicillin-resistant Staphylococcus aureus (MRSA)
Time: 08:30-10:30, July 31, 2011 (Sunday); Place: Room No.311A, 3rd Floor, BICC
|
|
Chair:
|
Dr. Adriana E Rosato, Associate Professor, The Methodist Research Institute, USA
|
|
08:30-08:50
|
Title: Insights into New Signal Pathways Involved in β-lactam Resistance Expression in MRSA
Dr. Adriana E Rosato, Associate Professor, The Methodist Research Institute, USA
|
|
08:50-09:10
|
Title: Patients′Experiences of being Infected with MRSA at a Hospital and Subsequently Source Isolated
Dr. Eva Birgit Skyman, Researcher, Sahlgrenska University Hospital, Sweden
|
|
09:10-09:30
|
Title: Community Acquired Methicillin-resistant Staphylococcus Aureus: Not just a Case of Staphylococcal Cassette Chromosome Mec Type IV or V Acquisition
Dr. Frances O’Brien (Frances Gray Lim), Research Scientist, Curtin University, Australia
|
|
09:30-09:50
|
Title: Sustained Reduction of Environmental MRSA Contamination by Copper and Its alloys: Possible Application for Infection Prevention and Control in Hospital
Dr. Takeshi Sasahara, Assistant Professor, Kitasato University School of Medicine, Japan
|
|
09:50-10:10
|
Title: Implications of MRSA in the Surgical Patient
Dr. Sameena Hassan, Core Surgical Trainee Trauma & Orthopaedics, Ninewells Hospital and Medical School, UK
|
|
10:10-10:30
|
Coffee Break
|
|
SBI 5: Development of Effective Antibiotics against MRSA, VRE and VRSA
Time: 08:30-11:20, July 31, 2011 (Sunday); Place: Room No.311B, 3rd Floor, BICC
|
|
Chair:
|
Mr. Vincent Hernandez, Director, Medicinal Chemistry, Anacor Pharmaceuticals, USA
|
|
08:30-08:55
|
Title: Discovery of Bicyclolides for the Treatment of Serious Gram-positive Infections
Dr. Yat Sun Or, Senior Vice President & Chief Scientific Officer, Enanta Pharmaceuticals, Inc., USA
|
|
08:55-09:20
|
Title: Overcoming Resistance; A View on the Challenges and Pipeline for MRSA
Mr. Vincent Hernandez, Director, Medicinal Chemistry, Anacor Pharmaceuticals, USA
|
|
09:20-09:45
|
Title: Case Studies around Antibiotic Challenges in Treating Deep Seated Infection with VRE, MSSA and MRSA
Dr. Erica Louise Teare, Director, Infection Prevention and Control, Mid Essex Hospital, UK
|
|
09:45-10:10
|
Title: Liposomal Vancomycin: Targeting Intracellular Parasitism in MRSA Infection
Dr. Andrew S. Pumerantz, Associate Professor & Chair, Western University of Health Sciences College of Osteopathic Medicine of the Pacific, USA
|
|
10:10-10:30
|
Coffee Break
|
|
10:30-10:55
|
Title: Resistance-modifying Activity from Novel Codonopsinine Derivatives against Methicillin-resistant Staphylococcus Aureus (MRSA)
Mr. Azmi Johari Saiful, Research Officer, Forest Research Institute Malaysia, Malaysia
|
|
10:55-11:20
|
Title: Development of New Drugs against Multiresistent Bacteria
Dr. Julianna F.C. de Albuquerque, Professor, Medicinal Chemistry, Antibiotics Department, Federal University of Pernambuco, Brazil
|
|
SBI 6: New Drug Development for Bad Bugs
Time: 10:30-12:10, July 31, 2011 (Sunday); Place: Room No.311A, 3rd Floor, BICC
|
|
Chair:
|
Dr. Kyung-soo Hahm, Professor & Director, Institute of Medical Science, Chosun University School of Medicine, South Korea
|
|
Co-Chair:
|
Dr. Ian Morrissey, Director, Anti-Infectives Microbiology, Quotient Bioresearch Ltd., UK
|
|
10:30-10:50
|
Title: How do We Get the Aantibiotics We Need? - The Opportunities and Challenges Posed and Lessons Learned During Recent Reviews of Drug Development Programes by the EU and Us
Dr. Flic Gabbay, Senior Partner & Non-executive Director, TranScrip Partners LLP, UK
|
|
10:50-11:10
|
Title: Antimicrobial Peptides for MDR and Biofilm Forming Bacterial Imfections
Dr. Kyung-soo Hahm, Professor & Director, Institute of Medical Science, Chosun University School of Medicine, South Korea
|
|
11:10-11:30
|
Title: How do We Get the Antibiotics We Need? – Recent Antibiotic Drug Development, Initiatives and Proposals to Encourage New Approaches
Dr. Richard Bax, Senior Partner, TranScrip Partners LLP, UK
|
|
11:30-11:50
|
Title: New Carbapenems
Dr. Ian Morrissey, Director, Anti-Infectives Microbiology, Quotient Bioresearch Ltd., UK
|
|
11:50-12:10
|
Title: Carbapenem Activity against Anaerobic Bacteria; The Clinical Laboratory Approach
Dr. Nurver (Toprak) Ulger, Associate Professor, Marmara University School of Medicine, Turkey
|
|
SBI 7: Vancomycin Intermediate/Resistant Staphylococcus aureus (VISA/VRSA), and Vancomycin-resistant Enterococcus (VRE)
Time: 13:30-14:45, July 31, 2011 (Sunday); Place: Room No.310, 3rd Floor, BICC
|
|
Chair:
|
Dr. Hildegard Adler, Deputy Head, Division of Clinical Microbiology, University Hospital Basel, Switzerland
|
|
13:30-13:55
|
Title: Detection of Vancomycin-resistant Enterococci (VRE) in a Low Prevalence Setting
Dr. Hildegard Adler, Deputy Head, Division of Clinical Microbiology, University Hospital Basel, Switzerland
|
|
13:55-14:20
|
Title: Molecular and Genetic Mechanisms of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus (VISA)
Dr. Longzhu Cui, Associate Professor, Juntendo University, Japan
|
|
14:20-14:45
|
Title: New Strategies for Designing and Optimizing Antibacterial Agents to Fight Against Vancomycin-resistant Gram-positive Pathogens
Dr. Abugafar M. L. Hossion, Laboratory Research Associate, Department of Medical and Bioengineering Science, Okayama University, Japan
|
|
SBI 8: Other Notorious Superbugs
Time: 13:30-17:35, July 31, 2011 (Sunday); Place: Room No.311A, 3rd Floor, BICC
|
|
Chair:
|
Dr. Xiuping Jiang, Associate Professor, Clemson University, USA
|
|
Co-Chair
|
Dr. Mueen Aslam, Research Scientist, Agriculture and Agri-Food Canada, Canada
|
|
13:30-13:55
|
Title: Molecular Mechanisms Underlying Mucosal Defense Responses against Streptococcus Pneumoniae
Dr. Un-Hwan Ha, Professor, Korea University School of Science and Technology, South Korea
|
|
13:55-14:20
|
Title: Transmission and Control of Escherichia Coli O157:H7 during Vegetable Production on Farm
Dr.Xiuping Jiang, Associate Professor, Clemson University, USA
|
|
14:20-14:45
|
Title: Characterization of Cronobacter Isolates from Various South African Food Sources
Dr.Piet Johannes Jooste, Professor, Tshwane University of Technology, South Africa
|
|
14:45-15:10
|
Title: The Outer Structures of the Bacillus Anthracis Spore: Roles in Survival, Dispersal and Disease
Dr. Adam Driks, Associate Professor, Loyola University, USA
|
|
15:10-15:30
|
Coffee Break
|
|
15:30-15:55
|
Title: Animal Prevalence, and Meat Contamination of STEC
Dr. Mueen Aslam, Research Scientist, Agriculture and Agri-Food Canada, Canada
|
|
15:55-16:20
|
Title: Virulence potential of Biofilm-forming Salmonella Typhimurium under Different Stress Conditions
Dr. Juhee Ahn, Associate Professor, Kangwon National University, South Korea
|
|
16:20-16:45
|
Title: Cephalosporin-resistant Neisseria Gonorrhoeae, The Next Superbug?
Dr. Alje P. van Dam, Clinical Microbiologist, Public Health Laboratory, Municipal Health Department, and Department of Medical Microbiology, OLVG General Hospital, The Netherlands
|
|
16:45-17:10
|
Title: The Deubiquitinase Activity of the Salmonella-secreted Effector, Ssel, Alters Host Cell Lipid During Infection
Dr. Ellen T. Arena, Research Fellow, Molecular Microbial Pathogenesis Unit, Institut Pasteur, France
|
| 17:10-17:35 |
Title: Evolution of Shiga Toxin-producing Escherichia coli O157: Eight Major Lineages of Human and Cattle Origin Strain Signature Genotypes
Dr. Michael L. Clawson, Research Molecular Biologist, USDA, ARS, U.S. Meat Animal Research Center, USA
|
|
SBI 9: Helicobacter spp.and Other Gastrointestinal Infectious Diseases
Time: 13:30-15:30, July 31, 2011 (Sunday); Place: Room No.311B, 3rd Floor, BICC
|
|
Chair:
|
Dr. Tat-Kin Tsang, Professor, University of Chicago, USA
|
|
13:30-13:55
|
Title: The Pathophysiology and Problems in Diagnosis of Helicobacter Pylori Infection
Dr. Tat-Kin Tsang, Professor, University of Chicago, USA
|
|
13:55-14:20
|
Title: Prescript-AssistTM Probiotic-prebiotic Complex Efficacy in Treatment of Gastrointestinal Disorders (IBS, Colitis, and Diarrhea): Clinical and Future Human Microbiome Research Implications
Dr. Alvah C. Bittner, Principal Research Scientist, Bittner & Associates, USA
|
|
14:20-14:45
|
Title: Evaluation of Natural Product, Refined Deep Seawater, for Helicobacter Pylori Colonization and Intestinal Flora Condition, And Its Application
Dr. Hiroaki Takeuchi, Associate Professor, Department of Clinical Laboratory Medicine, Kochi Medicinal School, Japan
|
|
14:45-15:10
|
Title: One-step Chromatographic Purification and Functional Characterization of Recombinant Helicobacter Pylori Neutrophil- Activating Protein Expressed in Bacillus Subtilis
Dr. Hua-Wen Fu, Associate Professor, National Tsing Hua University, Taiwan
|
|
15:10-15:30
|
Coffee Break
|
|
SBI 10: New Approaches to Antibacterial Drug Discovery
Time: 15:30-17:10, July 31, 2011 (Sunday); Place: Room No.311B, 3rd Floor, BICC
|
|
Chair:
|
Dr. Katherine Young, Collaboration Lead, Infectious Disease, MSD, USA
|
|
15:30-15:55
|
Title: MK-7655: A Class A and C b-lactamase Inhibitor
Dr. Katherine Young, Collaboration Lead, Infectious Disease, MSD, USA
|
|
15:55-16:20
|
Title: Ensemble-based Virtual Screening: Potential Lead Compounds against Isocitrate Lyase
Dr. Yee Siew Choong, Lecturer, Universiti Sains Malaysia, Malaysia
|
|
16:20-16:45
|
Title: Development of New Inhibitors against Bacterial Transglycosylases
Dr. Wei-Chieh Cheng, Associate Research Fellow, Academia Sinica, Taiwan
|
|
16:45-17:10
|
Title: Why Searching for the Next Antimicrobial Drug
Dr. Kalantar Enayat, Associate Professor, Kurdistan University of Medical Sciences (KUMSc), Iran
|
|
SBI 11: New Strategies of Discovering Antibacterial Agents
Time: 08:30-09:45, August 1st, 2011 (Monday); Place: Room No.310, 3rd Floor, BICC
|
|
Chair:
|
Dr. Glenn S Tillotson, Vice President, Optimer Pharmaceuticals, USA
|
|
Co-Chair:
|
Dr. Olga Genilloud, Director, Fundación MEDINA, Spain
|
|
08:30-08:55
|
Title: Fidaxomicin, A New Agent for the Treatment of Clostridium difficile
Dr. Glenn S Tillotson, Vice President, Optimer Pharmaceuticals, USA
|
|
08:55-09:20
|
Title: Current Challenges in the Discovery of Novel Antibacterials from Microbial Natural Products
Dr. Olga Genilloud, Director, Fundación MEDINA, Spain
|
|
09:20-09:45
|
Title: Receptor of Cationic Antimicrobial Peptide On Gram-negative Bacteria
Dr. You-Di Liao, Deputy Director, Institute of Biomedical Sciences, Academia Sinica, Taiwan
|
|
SBI 12 Young Scientist Forum
Time: 13:30-17:35, August 1st, 2011 (Monday); Place: Room No.310, 3rd Floor, BICC
|
|
Chair:
|
Dr. Chen Charles Xie, University of Melbourne, Australia
|
|
13:30-13:55
|
Title: Evaluation of Sexually Transmitted Infections in the Slovak Republic in the Period of Last Twenty Years
Dr. Danka Svecova, Associate Professor, Comenius University, Slovak Republic
|
|
13:55-14:20
|
Title: Engineering Non-coding RNA Regulatory Systems in Microbes
Dr. Lei Qi, University of California, USA
|
|
14:20-14:45
|
Title: Comparison of the Bacterial Isolates and Antibiotic Resistance Patterns of Elderly Nursing Home and General Community Patients
Dr. Chen Charles Xie, University of Melbourne, Australia
|
|
14:45-15:10
|
Title: Mycobacterial Lymphadenitis in Children: Advantages of Quantitative Real Time PCR in Diagnosis and Identifying Sources of Infection
Dr. Marija Kaevska, Veterinary Research Institute, Czech Republic
|
|
15:10-15:30
|
Coffee Break
|
|
15:30-15:55
|
Title: Transcriptional Profiles Response of methicillin-resistant Staphylococcus aureus to Pentacyclic Triterpenoids
Dr. Pooi Yin Chung, Monash University, Malaysia
|
|
15:55-16:20
|
Title: Low-temperature Plasma Generated by Electrical Gas Discharge - A Topical Microbicidal Tool at Atmospheric Pressure Air
Dr. Andreas Helmke, University of Applied Sciences and Arts, Germany
|
|
16:20-16:45
|
Title: Carbapenem Resistance in Pseudomonas Aeruginosa
Dr. Georgios Meletis, Aristotle University of Thessaloniki, Greece
|
|
16:45-17:10
|
Title: RNA Polymerase Primary σ70 Targeting with Antisense Peptide-PNAs Provides Broad Spectrum, Low Resistance Bacteriocidal Effects in Multidrug-resistant Gram-negatives
Dr. Hui Bai, Fourth Military Medical University, China
|
|
17:10-17:35
|
Title: Isolation of Diarrhoeagenic Escherichia Coli from Foods By Colony-hybridization Method With Hydrophobic-grid Membrane Filters
Dr. Lili Wang, Osaka City University, Japan
|
|
